India Patent Appeals Board Revokes Pair Of Allergan Glaucoma Patents
This article was originally published in PharmAsia News
Executive Summary
India's Intellectual Property Appellate Board revoked two patents held by Allergan for glaucoma drugs Ganfort (bimatropost) and Combigan (brimonidine).